Core Insights - BioStem Technologies, Inc. reported a significant decline in revenue for Q4 2025, with net revenue of $10.1 million, a 55% decrease compared to Q4 2024, primarily due to reimbursement uncertainty and competitive pressures [5][6] - The company completed the acquisition of BioTissue Holdings Inc. in January 2026, which is expected to enhance its product portfolio and commercial reach [9][10] - BioStem anticipates first quarter 2026 revenue to be between $5 million and $6 million, with expectations for growth in the hospital business in the second half of the year [12] Recent Financial and Business Highlights - CEO Jason Matuszewski emphasized the company's strengthened position and diversification following the BioTissue acquisition, which expands its market presence [3] - The gross profit margin for Q4 2025 was 97%, up from 84% in Q4 2024, attributed to a shift in product mix [5] - Operating expenses increased to $17.3 million in Q4 2025 from $10.7 million in Q4 2024, largely due to charges for potentially uncollectible accounts receivable [6] Financial Results Overview - For the full year 2025, net revenue was $47.5 million, down from $69.7 million in 2024, driven by lower wound care volume [8] - Gross profit for 2025 was $44.4 million, or 94% of net revenue, compared to $55.9 million or 80% in 2024 [10] - The company reported a GAAP net loss of $6.6 million for 2025, a significant decline from a net income of $31 million in 2024 [11] Cash Position and Future Outlook - As of December 31, 2025, cash equivalents totaled $29.5 million, which decreased to approximately $16 million post-BioTissue acquisition [7] - The company expects to drive sequential and year-over-year growth in the hospital business after integrating the BioTissue assets and expanding its salesforce [12]

Core Insights - Apple iSports has appointed Ian Wilding as Fractional Chief Innovation Officer to guide strategic innovation initiatives and support the company's transition from OTC-QB to Nasdaq listing [1][2][3] Company Overview - Apple iSports operates at the intersection of gaming infrastructure, digital entertainment, and emerging market opportunities, focusing on disciplined growth and stakeholder engagement [3][5] - The company provides gaming, wagering, and ecosystem solutions to both B2B and B2C markets [6] Leadership and Experience - Ian Wilding brings over 25 years of experience in public companies and growth-stage ventures, emphasizing strategic clarity and market insight [4][8] - Wilding's role will involve helping the leadership team make informed decisions based on real market signals, essential for Nasdaq readiness [5] Strategic Focus - The appointment of Wilding reflects Apple iSports' commitment to disciplined growth and operating at standards expected of leading public companies [5] - The management team has over four decades of experience in regulated markets, now leveraging that expertise in the U.S. market [7]